Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
2018 · Neuron · 698 citations
https://doi.org/10.1016/j.neuron.2018.02.027
M
Matthew C. Kiernan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.1K
Papers
44.5K
Citations
107
h-index
554
i10-index
Matthew C. Kiernan is an academic researcher from Tufts Medical Center. The author has contributed to research in topics: Amyotrophic Lateral Sclerosis Research & Neurogenetic and Muscular Disorders Research & Parkinson's Disease Mechanisms and Treatments. The author has an h-index of 107, co-authored 937 publications.
ORCID: 0000-0001-9054-026XPapers by this author
worksGenome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
2016 · Nature Genetics · 620 citations
https://doi.org/10.1038/ng.3622
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
2021 · Nature Genetics · 522 citations
https://doi.org/10.1038/s41588-021-00973-1
Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management
2015 · Circulation · 355 citations
https://doi.org/10.1161/cir.0000000000000093
Consensus for experimental design in electromyography (CEDE) project: Amplitude normalization matrix
2020 · Journal of Electromyography and Kinesiology · 298 citations
https://doi.org/10.1016/j.jelekin.2020.102438
Improving clinical trial outcomes in amyotrophic lateral sclerosis
2020 · Nature Reviews Neurology · 280 citations
https://doi.org/10.1038/s41582-020-00434-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat